We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Merck Patent For Contraceptive NuvaRing Nixed As Obvious

Law360, New York (August 30, 2016, 4:52 PM EDT) -- A Delaware federal judge has ruled following a bench trial that the asserted claims of a patent that covers Merck’s birth control device NuvaRing are invalid because of obviousness, handing a...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.